news aktuell GmbH

Europe needs Twisters campaign

Share

Researchers from all over Europe are organising high-density measurements of severe storms, similar to the new film Twisters.

(Wiener Neustadt, Austria

Severe weather researchers from 14 European countries want to work together to get to the bottom of severe thunderstorms so that they can provide better warnings in future. To this aim, they are currently planning the largest European measurement campaign on severe thunderstorms to date. "We want to use the latest technologies, such as weather drones. To do this, it is extremely important that mobile measurement teams get very close to the storms," says Alois Holzer, initiator of the European "TIM" measurement campaign to start in 2026.

As can be seen in the new movie Twisters, the European research teams will also be tackling the storms with the newest generation of weather sensors. "In contrast to some scenes in the entertainment film Twisters, however, the highest safety standards apply in our research campaign, and we have also made a joint commitment to responsible behaviour with regard to the environment and the local population," emphasises Holzer.  

The project is still looking for major donors for the individual mobile measurement teams. Alois Holzer says: "We hope that the kind of support from major donors possible in North America can also be achieved in Europe. We are also in dialogue with various public authorities."

TIM Field Campaign:                                                     www.tim-campaign.eu

The TWISTERS live expert talk will take place on Tuesday, 16 July 2024:

Expert Talk

11:30 CEST

10:30 WEST

Online

Participation:

Microsoft Teams live event

Registration via:

Microsoft Teams Event

Contacts

Stefan Eisenbach, Head of External Relations
ESSL, European Severe Storms Laboratory – Science and Training
Bräunlichgasse 6a/6, 2700 Wiener Neustadt
+43 664 73103344, stefan.eisenbach@essl.org
www.essl.org

About news aktuell GmbH

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release

youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye